CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 7. Cooperative cytotoxicity of IR in combination with the cPKC-specific inhibitor PKC-412. A, proliferation was assessed 48 h after treatment with PKC-412 (200 nM) and IR (2 Gy) or both in combination. B, cytosolic extracts from untreated cells (CTL) or from cells treated for 18 h with PKC-412 (200 nM), IR (5 Gy), or both in combination (PKC-412+IR) were probed using the monoclonal anti-cytochrome c antibody. C, caspase-9 activity was determined 18 h after treatment using the caspase-9-specific peptide substrates (Ac-LEHD-pNA) in cellular extracts derived from control cells (CTL) or from cells treated with PKC-412 (200 nM), IR (5 Gy), or both in combination.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation